P. Hilgard

2.0k total citations
81 papers, 1.6k citations indexed

About

P. Hilgard is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P. Hilgard has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in P. Hilgard's work include Blood properties and coagulation (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Bone health and treatments (6 papers). P. Hilgard is often cited by papers focused on Blood properties and coagulation (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Bone health and treatments (6 papers). P. Hilgard collaborates with scholars based in Germany, United Kingdom and Belgium. P. Hilgard's co-authors include J. Engel, Clemens Unger, R. D. Thornes, B. Maat, Jurij Stekar, Bernhard Kutscher, H. Eibl, C. G. Schmidt, J. Pohl and Christine Unger and has published in prestigious journals such as Journal of Hepatology, British Journal of Cancer and Diabetologia.

In The Last Decade

P. Hilgard

79 papers receiving 1.5k citations

Peers

P. Hilgard
Comparison fields: 5 of 110
  • Molecular Biology 678
  • Oncology 377
  • Pulmonary and Respiratory Medicine 231
  • Hematology 218
  • Cancer Research 195
Replace Eric Scholar with:
Eric Scholar United States
A Goldin United States
Kiyoshi Okamoto Japan
Thomas J. Brown United States
Willi Kreis United States
Tina Colombo Italy
Daniel Glaubiger United States
Donna Glover United States
Sherman F. Stinson United States
Shinya Abe Japan
Eric Scholar United States View profile →
Citations per field, relative to P. Hilgard
P. Hilgard · 1×
Citations per year, relative to P. Hilgard
P. Hilgard · 1×

Countries citing papers authored by P. Hilgard

Since Specialization
Citations

This map shows the geographic impact of P. Hilgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Hilgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Hilgard more than expected).

Fields of papers citing papers by P. Hilgard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Hilgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Hilgard. The network helps show where P. Hilgard may publish in the future.

Co-authorship network of co-authors of P. Hilgard

This figure shows the co-authorship network connecting the top 25 collaborators of P. Hilgard. A scholar is included among the top collaborators of P. Hilgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Hilgard. P. Hilgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 6
2 0
3 2
4 119
5
Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.
26
6 9
7 13
8 89
9 18
10
Alkylphosphocholines : new drugs in cancer therapy
50
11 24
12 31
13 11
14 90
15 3
16 3
17
Metastasis, clinical and experimental aspects : proceedings of the EORTC Metastasis Group International Conference on Clinical and Experimental Aspects of Metastasis, London, April 21-23, 1980
1
18 2
19 75
20 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026